Inventiva S.A [IVA] vs Abivax SA [ABVX] Detailed Stock Comparison
Inventiva S.A
Euronext
Loading...
Abivax SA
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 17 vital metrics comparison: Inventiva S.A wins in 7 metrics, Abivax SA wins in 9 metrics, with 1 ties. Abivax SA appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Inventiva S.A | Abivax SA | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -1.54 | -24.79 | Abivax SA |
| Price-to-Book Ratio | -1.72 | -91.19 | Abivax SA |
| Debt-to-Equity Ratio | -1.70 | -2.04 | Abivax SA |
| PEG Ratio | -3.34 | -47.21 | Abivax SA |
| EV/EBITDA | -5.57 | -24.20 | Abivax SA |
| Profit Margin (TTM) | 0.00% | 0.00% | Tie |
| Operating Margin (TTM) | -384.43% | -4,440.88% | Inventiva S.A |
| Return on Equity | 172.73% | -499.78% | Inventiva S.A |
| Return on Assets (TTM) | -63.60% | -57.74% | Abivax SA |
| Free Cash Flow (TTM) | $-86.26M | $-154.72M | Inventiva S.A |
| 1-Year Return | 185.54% | 590.57% | Abivax SA |
| Price-to-Sales Ratio (TTM) | 46.08 | 892.23 | Inventiva S.A |
| Enterprise Value | $522.47M | $4.49B | Abivax SA |
| EV/Revenue Ratio | 37.07 | 746.06 | Inventiva S.A |
| Revenue per Share (TTM) | $0 | $0 | Inventiva S.A |
| Earnings per Share (Diluted) | $-3.08 | $-3.09 | Inventiva S.A |
| Beta (Stock Volatility) | 0.74 | 0.13 | Abivax SA |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Inventiva S.A vs Abivax SA Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Inventiva S.A | 1.39% | 7.48% | 17.62% | 74.26% | 71.74% | 124.64% |
| Abivax SA | 1.30% | 2.48% | 7.49% | 1,257.14% | 926.28% | 865.66% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Inventiva S.A | 185.54% | 30.22% | -54.86% | -42.82% | -42.82% | -42.82% |
| Abivax SA | 590.57% | 784.28% | 273.14% | 270.00% | 239.61% | 239.61% |
News Based Sentiment: Inventiva S.A vs Abivax SA
Inventiva S.A
News based Sentiment: MIXED
September presented a mixed bag for Inventiva, with positive analyst upgrades and active investor engagement countered by downward revisions to revenue estimates and stock price fluctuations. The company's progress in clinical trials and potential as an acquisition target add complexity to the investment picture, making it a high-risk, high-reward opportunity.
Abivax SA
News based Sentiment: POSITIVE
September was a strong month for Abivax, marked by positive Phase 3 trial results for obefazimod, a successful capital raise earlier in the year, and growing institutional investment. These developments led to increased analyst confidence, a surge in stock price, and inclusion in major indices, signaling a positive trajectory for the company.
Performance & Financial Health Analysis: Inventiva S.A vs Abivax SA
| Metric | IVA | ABVX |
|---|---|---|
| Market Information | ||
| Market Cap | €658.45M | €5.37B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 229,057 | 137,280 |
| 90 Day Avg. Volume | 287,655 | 93,960 |
| Last Close | €4.74 | €70.30 |
| 52 Week Range | €1.43 - €5.26 | €4.51 - €78.70 |
| % from 52W High | -9.98% | -10.67% |
| All-Time High | €16.30 (Jan 18, 2021) | €78.70 (Sep 08, 2025) |
| % from All-Time High | -70.92% | -10.67% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.30% | -0.81% |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | 0.00% |
| Operating Margin (TTM) | -3.84% | -44.41% |
| Return on Equity (TTM) | 1.73% | -5.00% |
| Debt to Equity (MRQ) | -1.70 | -2.04 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €-1.12 | €-0.76 |
| Cash per Share (MRQ) | €1.01 | €0.96 |
| Operating Cash Flow (TTM) | €-85,928,000 | €-135,515,008 |
| Levered Free Cash Flow (TTM) | €-56,252,248 | €-88,009,752 |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Inventiva S.A vs Abivax SA
| Metric | IVA | ABVX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -1.54 | -24.79 |
| Forward P/E | -3.34 | -47.21 |
| PEG Ratio | -3.34 | -47.21 |
| Price to Sales (TTM) | 46.08 | 892.23 |
| Price to Book (MRQ) | -1.72 | -91.19 |
| Market Capitalization | ||
| Market Capitalization | €658.45M | €5.37B |
| Enterprise Value | €522.47M | €4.49B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 37.07 | 746.06 |
| Enterprise to EBITDA | -5.57 | -24.20 |
| Risk & Other Metrics | ||
| Beta | 0.74 | 0.13 |
| Book Value per Share (MRQ) | €-1.12 | €-0.76 |
Financial Statements Comparison: Inventiva S.A vs Abivax SA
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IVA | ABVX |
|---|---|---|
| Revenue/Sales | €65,000 | €0 |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | €11.91M | €38.65M |
| Operating Income (EBIT) | €-13.67M | €-46.50M |
| EBITDA | €-13.43M | €-43.02M |
| Pre-Tax Income | €-14.27M | €-48.41M |
| Income Tax | €21,000 | €0 |
| Net Income (Profit) | €-14.30M | €-48.41M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IVA | ABVX |
|---|---|---|
| Cash & Equivalents | €96.56M | €103.58M |
| Total Current Assets | €111.51M | €132.67M |
| Total Current Liabilities | €120.73M | €105.74M |
| Long-Term Debt | €48.46M | €48.19M |
| Total Shareholders Equity | €-106.65M | €-6.59M |
| Retained Earnings | €-184.21M | €-486.52M |
| Property, Plant & Equipment | €10.72M | €484,000 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IVA | ABVX |
|---|---|---|
| Operating Cash Flow | €-24.55M | €-31.76M |
| Capital Expenditures | €-63,000 | €-44,000 |
| Free Cash Flow | €-12.13M | €-33.32M |
| Debt Repayment | €-1,000 | €-6.12M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | IVA | ABVX |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 229,057 | 137,280 |
| Average Daily Volume (90 Day) | 287,655 | 93,960 |
| Shares Outstanding | 95.66M | 63.35M |
| Float Shares | 50.52M | 34.26M |
| % Held by Insiders | 0.08% | 0.01% |
| % Held by Institutions | 0.69% | 0.48% |
Dividend Analysis & Yield Comparison: Inventiva S.A vs Abivax SA
| Metric | IVA | ABVX |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |